56 related articles for article (PubMed ID: 9216671)
1. In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells.
Picariello L; Fiorelli G; Benvenuti S; Brandi ML; Galli G; Malentacchi C; Montali E; Bigozzi U; Ficari F; Tonelli F
Anticancer Res; 1997; 17(3C):2099-104. PubMed ID: 9216671
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study.
Tonelli F; Valanzano R; Brandi ML
Surgery; 1994 Apr; 115(4):473-9. PubMed ID: 8165538
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells.
Levine L
BMC Cancer; 2004 Aug; 4():49. PubMed ID: 15310397
[TBL] [Abstract][Full Text] [Related]
4. Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.
Neubauer BL; Best KL; Goode RL; Heiman ML; Hoover DM; Robertson DW; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
Cancer Res; 1992 Sep; 52(17):4663-71. PubMed ID: 1511432
[TBL] [Abstract][Full Text] [Related]
5. Functional estrogen receptor beta in colon cancer cells.
Fiorelli G; Picariello L; Martineti V; Tonelli F; Brandi ML
Biochem Biophys Res Commun; 1999 Aug; 261(2):521-7. PubMed ID: 10425218
[TBL] [Abstract][Full Text] [Related]
6. Growth response of colon cancer cell lines to selective estrogen receptor modulators.
Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML
Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523
[TBL] [Abstract][Full Text] [Related]
7. Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Stabellini G; Balducci C; Lilli C; Marinucci L; Becchetti E; Carinci F; Calastrini C; Dolci C; Lumare E; Locci P
Biomed Pharmacother; 2008 Sep; 62(7):436-42. PubMed ID: 18155395
[TBL] [Abstract][Full Text] [Related]
8. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
Jordan VC; Gosden B
J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
[TBL] [Abstract][Full Text] [Related]
9. Molecular effects of antiestrogens (tamoxifen and LY117018) on estrogen-dependent glycoprotein (USP-1) synthesized and secreted by rat uterine epithelial cells.
Takeda A; Shimizu S
Endocrinology; 1988 Jul; 123(1):258-63. PubMed ID: 3383775
[TBL] [Abstract][Full Text] [Related]
10. Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018.
Uchiumi T; Mizoguchi H; Hagino Y; Kohno K; Kuwano M
Int J Cancer; 1991 Jan; 47(1):80-5. PubMed ID: 1702405
[TBL] [Abstract][Full Text] [Related]
11. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
Black LJ; Goode RL
Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
[TBL] [Abstract][Full Text] [Related]
12. Evidence for bioeffects of LY 139478 on the human pre-osteoclastic cell line FLG 29.1.
Fiorelli G; Gori F; Frediani U; Morelli AM; Falchetti A; Benvenuti S; Masi L; Brandi ML
Biochem Biophys Res Commun; 1995 Jun; 211(3):857-63. PubMed ID: 7598715
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1.
Fiorelli G; Martineti V; Gori F; Benvenuti S; Frediani U; Formigli L; Zecchi S; Brandi ML
Biochem Biophys Res Commun; 1997 Nov; 240(3):573-9. PubMed ID: 9398606
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
Calaf GM
Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen regulation of ectocervical cell differentiation.
Macinga D; Jain V; Sizemore N; Gorodeski GI; Eckert RL; Rorke EA
J Soc Gynecol Investig; 1995; 2(6):754-61. PubMed ID: 9420886
[TBL] [Abstract][Full Text] [Related]
16. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
Pihie AH; Stanslas J; Din LB
Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
[TBL] [Abstract][Full Text] [Related]
17. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
[TBL] [Abstract][Full Text] [Related]
18. Growth effects of tamoxifen on Lovo colon carcinoma cells and cultured cells from normal colonic mucosa.
Lointier P; Wildrick DM; Boman BM
Anticancer Res; 1992; 12(5):1523-5. PubMed ID: 1444215
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
20. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
